BioSpace News Archive

New Moon, the inaugural virtual Iftar celebration for St. Jude Children’s Research Hospital®, brings together Muslim Americans this Sunday, April 18, for an evening of fellowship and philanthropy to benefit the lifesaving mission of St. Jude: Finding cures. Saving children®.

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant, Cherry Lime Rickey, Golden Raspberry),

ARUP Laboratories announced the retirement of CEO Sherrie L. Perkins, MD, PhD, effective June 30, 2021.

Innovega Inc. received SEC qualification for its $15 million Regulation A+ offering which set in motion the conversion of reservations to completed investments.

Following guidance from the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA), Publix is suspending the administration of the Johnson & Johnson COVID-19 vaccine at all of its pharmacy locations.

Novartis Pharmaceuticals Canada Inc. is thrilled to be recognized as a Great Place to Work® and announce that Novartis in Canada has earned a spot on the “Top 50 Best Workplaces™" in the country

AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW) (the “Company”), a designer, developer, and manufacturer of custom and standard state-of-the-art RF components for Commercial, SATCOM, 5G, Quantum Computing, Space, Defense, and Military markets, announced today it received a developmental order from Amplify My Probe, Ltd

In just 30 months and despite facing a global pandemic, Penn State and collaborating companies have successfully established and advanced the industrial biotechnology ecosystem and talent pipeline at the university.

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company, is pleased to announce that its President and CEO, Serge Verreault will be presenting at the upcoming Bloom Burton & Co. Healthcare Investor Conference taking place virtually on April 20 and 21, 2021.

eQcell Inc. Canada’s premier clinical-stage regenerative medicine company addressing conditions and diseases affecting sporting and domestic animals globally, announces the appointment to its Board of Directors of Mr. David Allan.